Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
82 participants
INTERVENTIONAL
2007-11-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Progressive Mobility Program and Technology to Improve the Level of Physical Activity and Functionality of ICU Patients
NCT02889146
Haemodynamic and Metabolism Response During Early Rehabilitation in Sedated Patients
NCT02920684
Effect of Therapeutic Modalities on the Physical Fitness and Functional Capacity in Critical Patient
NCT01881477
Optimizing Training in Severe Post-Stroke Walking Impairment
NCT04721860
Comparison of Two High-intensity Gait Training Interventions on Contraversive Pushing Behaviors in Individuals Poststroke
NCT04550039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Compare patient responses to selected modes of therapy (activity) without and with an ETM protocol
1. Molecular responses: markers of inflammation interleukin (IL)-6 and IL-10
2. Physiological responses: peripheral oxygen saturation, heart rate, blood pressure, new dysrhythmias
3. Safety/Unsafe events including pain, fatigue, line or tube dislodgement, fall or near fall
2. Determine the associations between duration and level of activity/ETM achieved and outcomes:
1. occurrence of delirium
2. occurrence of ventilator associated pneumonia
3. occurrence of deep vein thrombosis or pulmonary emboli
4. occurrence of acquired pressure ulcer
5. muscle strength
6. number of days mechanically ventilated
7. discharge location (after ICU)
3. Describe strategies used in the ICU to initiate and implement activity with and without an ETM protocol
1. use of personnel such as registered nurses, physical therapists, respiratory therapist and nursing assistants
2. use of equipment such as a walker, lift device, belt or bed
3. perception of sufficient time and abilities
4. Describe patient factors that are associated with implementation of ETM
1. Potentially modifiable exemplars: sedation, site of vascular access, physician orders
2. Potentially nonmodifiable exemplars: weight, consciousness, hemodynamic instability, terminal condition
This is a prospective, longitudinal, repeated measures study with a control period, run-in period and intervention period. Data will be collected during all three periods for comparison. During the control period, patients will receive standard care. Standard care in this institution does not include a program of progressive or early mobility but does include activities similar to the ETM protocol, implemented at the discretion of the staff. During the run-in period, subjects will receive a mix of standard care and the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
RA begins data collection with chart review for demographic and explanatory variables, collects data for baseline muscle strength. During standard care period, PM will obtain information about the plan for activity for enrolled patients (turning, complete or partial weight-bearing i.e., reverse Trendelenberg positioning, ROM, sitting and walking) through discussion with the direct providers. RA will interview one provider about factors which influence the decision to implement activity or provide bedrest, including the presence of orders for bedrest or physical therapy. If activity is planned, the PM will observe and record the type and duration of activity, drawing serum biomarkers 20 minutes before and 20 minutes after the activity. If no activity is planned or activity duration is less than 10 minutes, serum for only baseline inflammatory biomarkers will be drawn. The RA will collect outcomes data within 24 hours of discharge from the ICU.
No interventions assigned to this group
2
Identical procedures for date recruitment, consent and data collection will occur. In this phase, the Project Manager will promote the use of the ETM protocol through coaching (e.g., reminding staff of benefits of mobility, identification of available resources, or suggesting cessation of bedrest orders) and by participating in planning at least one 20-minute activity.
ETM protocol
ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ETM protocol
ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FiO2 \< 60% and PEEP less than 10 cmH20
* hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline)
* baseline (rest) vitals signs of HR 50-110
* mean arterial pressure (MAP) 60-100 mmHg
* peripheral oxygenation saturation (SpO2) greater than 88%
* Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement
* a high degree of dependency on others for positioning is acceptable
* there are no exclusions based on gender or minority status.
Exclusion Criteria
* myasthenia gravis
* new quadriplegia
* coma
* increased intracranial pressure
* unrepaired hip fracture and multiple lower extremity fractures
* Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded
* concurrent use of a continuous lateral rotation bed
* patients for high risk of death will also be excluded
* MICU admission following a hospital stay of \>9 days in the past months
* age \>80 in the presence of 2 or more life-threatening illnesses
* diagnosis of an active stage IV malignancy
* status post cardiac arrest
* diagnosis of intracerebral hemorrhage requiring mechanical ventilation
* subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hill-Rom
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Case Western Reserve University, Francis Payne Bolton School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chris Winkelman, PhD
Role: PRINCIPAL_INVESTIGATOR
Case Western Reserve University
References
Explore related publications, articles, or registry entries linked to this study.
Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-0076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.